Healthcare AI projects tend to fail for reasons that have nothing to do with model quality: EHR vendor API limitations discovered mid-build, HIPAA-aligned data handling requirements not scoped until legal review, or a use case that sounded valuable in a planning meeting turning out to be technically infeasible given the client's actual systems. The technical bar for the AI itself is often the easier part; the real work is navigating clinical, legal, and systems constraints that are specific to healthcare and easy to underestimate from outside it.

What makes AI work different here

Where we typically start

We usually begin healthcare engagements with a structured readiness assessment: mapping what a client's existing systems (EHR, patient messaging, billing) actually support programmatically, before evaluating specific AI use cases against that reality. This catches infeasible ideas in week one instead of week eight, and it's shaped how we scope every healthcare engagement since.

Services we typically provide

Case studies from this industry

Frequently asked questions

Is it safe to use AI with patient data given HIPAA requirements?

It can be, but the architecture needs to be designed around HIPAA-aligned data handling from the start, not added afterward. This includes how data is stored and transmitted, access logging, and often keeping certain data processing on infrastructure your organization controls rather than sending it to third-party services without a proper business associate agreement in place.

Why would an AI project fail even if the model itself works well?

Most healthcare AI project failures we've seen come from systems integration and compliance issues discovered late, not model performance. An EHR vendor's API might not support the access a use case needs, or a use case that seemed fine in planning turns out to need a compliance review process that adds months. Scoping these constraints in week one avoids discovering them after a build has already started.

How do you handle the higher accuracy bar for clinical use cases?

Generally through more conservative confidence thresholds and more human-in-the-loop review than a typical business application would use, and rigorous evaluation against a labeled dataset specific to the use case before anything goes into production. We also scope clinical-facing use cases separately from administrative ones, since they warrant different levels of caution.